Mini Review
Published on 04 Mar 2024
The TGF-β superfamily as potential therapeutic targets in pancreatic cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1362247
- 2,519 views
Type at least 3 characters
1,765 articles
Articles
Correction
Published on 29 Feb 2024
Corrigendum: Carnosol, a natural polyphenol, inhibits migration, metastasis, and tumor growth of breast cancer via a ROS-dependent proteasome degradation of STAT3
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1235201
- 1,000 views
Review
Published on 28 Feb 2024
Expression and prognosis of ADAMTS18 in different tumors
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1347633
- 1,182 views
Editorial
Published on 28 Feb 2024
Editorial: Integrating transcriptional modulation in systemic tumor therapy
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1385766
- 770 views
Systematic Review
Published on 28 Feb 2024
A systematic review and Bayesian meta-analysis assessing intelectin-1 in cancer patients and healthy individuals
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1198555
- 1,321 views
Review
Published on 26 Feb 2024
Ferroptosis and EMT resistance in cancer: a comprehensive review of the interplay
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1344290
- 3,566 views
- 3 citations
Mini Review
Published on 26 Feb 2024
In vitro and in vivo modeling systems of supratentorial ependymomas
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1360358
- 1,501 views
Original Research
Published on 26 Feb 2024
Oncopig bladder cancer cells recapitulate human bladder cancer treatment responses in vitro
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1323422
- 1,851 views
- 1 citation
Correction
Published on 22 Feb 2024
Corrigendum: ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1381151
- 613 views
Review
Published on 21 Feb 2024
Current treatment strategies targeting histone deacetylase inhibitors in acute lymphocytic leukemia: a systematic review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1324859
- 1,783 views
- 2 citations
Case Report
Published on 06 Feb 2024
Case report: Response to Savolitinib/EGFR-TKI combination in NSCLC patients harboring concurrent primary MET amplification/overexpression and EGFR mutation
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1297156
- 1,285 views
Original Research
Published on 06 Feb 2024
Selective inhibition of DNA ligase IV provides additional efficacy to the treatment of anaplastic thyroid cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1323313
- 2,169 views
Original Research
Published on 05 Feb 2024
The prognosis of TP53 and EGFR co-mutation in patients with advanced lung adenocarcinoma and intracranial metastasis treated with EGFR-TKIs
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1288468
- 1,805 views
- 2 citations
Case Report
Published on 02 Feb 2024
Sintilimab combined with axitinib in the treatment of advanced chromophobe renal cell carcinoma: a case report
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1325999
- 1,467 views
- 1 citation
Original Research
Published on 31 Jan 2024
Outcomes and complications of postoperative seroma cavities following soft-tissue sarcoma resection
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1250069
- 3,568 views
Review
Published on 30 Jan 2024
Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1331355
- 5,830 views
- 10 citations